Restore Mind Medicine
Dr. Scott Freeman
Dr.
Freeman has broad, executive-level experience in the
biopharmaceutical industry and an extensive understanding of the
Company, its business, and its clinical development requirements. Dr.
Freeman served as Co-Founder, President, and Chief Medical Officer
of MindMed from July 2019 to August 2020, where he founded the
Company's pivotal and fruitful relationship with the University
Hospital Basel and pioneered the Company's clinical development
into lysergic acid diethylamide ("LSD"). He worked for over a decade
in the psychedelic industry as the Chief Medical Officer of Savant
HWP, Inc. Dr. Freeman has brought a drug to market after just one
Phase II trial and has over three decades of experience in developing
drug products and running clinical trials.
91View entire presentation